Early-phase clinical trials open new opportunities
January 16, 2013
Rachel E. Sanborn, M.D.
Co-medical director, Providence Thoracic Oncology Program
Providence Cancer Center
The rapid pace of development of mutation-targeted anti-cancer agents, and recent breakthroughs in immune-based cancer therapy, have led to an unprecedented era of cancer research and discovery.
Clinical trials have begun to focus more on smaller studies, with some agents approved for use based upon significant results from early-phase clinical research. Oncology researchers at Providence Cancer Center are focused on expanding opportunities for patients with all types of cancer to participate in clinical trials, including exciting early-phase studies.
Read the full story from Dr. Sanborn »